|
1BHO
MAC-1 I DOMAIN MAGNESIUM COMPLEX
Deposited 1998-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain 1
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
Chain 2
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;CRYSTALS WERE GROWN BY VAPOR DIFFUSION ON SITTING DROP BRIDGES. THE WELL MIX OF 20-24% PEG6000 BUFFERED WITH 100 MM NA ACETATE PH 5.0 WAS MIXED 1:1 WITH 3 UL OF I DOMAIN PROTEIN (20-30 MG/ML, 50 MM HEPES PH 7.0, 0.025% NA AZIDE). CRYSTALS WERE STABLIZED IN 100MM MGCL2, 100 MM NA ACETATE 5.0, 26% PEG6000 FOR DATA COLLECTION., vapor diffusion - sitting drop
|
Resolution 2.70 Å
|
|
1BHQ
MAC-1 I DOMAIN CADMIUM COMPLEX
Deposited 1998-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain 1
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
Chain 2
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
|
Not recorded
|
CD CADMIUM ION × 3
ACE ACETYL GROUP × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;CRYSTALS WERE GROWN BY VAPOR DIFFUSION ON SITTING DROP BRIDGES. THE WELL MIX OF 20-24% PEG6000 BUFFERED WITH 100 MM NA ACETATE PH 5.0 WAS MIXED 1:1 WITH 3 UL OF I DOMAIN PROTEIN (20-30 MG/ML, 50 MM HEPES PH 7.0, 0.025% NA AZIDE). CRYSTALS WERE STABLIZED IN 10MM CDCL2, 100 MM NA ACETATE 5.0, 26% PEG6000 FOR DATA COLLECTION., vapor diffusion - sitting drop
|
Resolution 2.70 Å
|
|
1IDN
MAC-1 I DOMAIN METAL FREE
Deposited 1998-06-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain 1
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
Chain 2
149–337(189 aa)
Fragment:MAC-1 ALPHA DOMAIN
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;CRYSTALS WERE GROWN BY VAPOR DIFFUSION ON SITTING DROP BRIDGES. THE WELL MIX OF 20-24% PEG6000 BUFFERED WITH 100 MM NA ACETATE PH 5.0 WAS MIXED 1:1 WITH 3 UL OF I DOMAIN PROTEIN (20-30 MG/ML, 50 MM HEPES PH 7.0, 0.025% NA AZIDE). CRYSTALS WERE STABLIZED IN 100 MM NA ACETATE 5.0; 26% PEG6000 FOR DATA COLLECTION., vapor diffusion - sitting drop
|
Resolution 2.70 Å
|
|
1IDO
I-DOMAIN FROM INTEGRIN CR3, MG2+ BOUND
Deposited 1996-03-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
148–331(184 aa)
Fragment:I-DOMAIN
|
Not recorded
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;pH 8.5
|
Resolution 1.70 Å
|
|
1JLM
I-DOMAIN FROM INTEGRIN CR3, MN2+ BOUND
Deposited 1996-04-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
143–334(192 aa)
Fragment:I-DOMAIN
|
Not recorded
|
MN MANGANESE (II) ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
|
|
1M1U
AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
Deposited 2002-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
139–331(193 aa)
Fragment:CD11b A-domain, Residues 123-315
|
Mutation:C128S
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;298 K;15% PEG8K, 0.1M Tris-HCl 8.2, 5mM CaCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.30 Å
R-free 0.248
|
|
1MF7
INTEGRIN ALPHA M I DOMAIN
Deposited 2002-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
144–335(192 aa)
Fragment:I domain
|
Mutation:A318C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.25 Å
R-free 0.223
|
|
1N9Z
INTEGRIN ALPHA M I DOMAIN MUTANT
Deposited 2002-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
144–335(192 aa)
Fragment:alpha M I domain
|
Mutation:C128A D132C K315C
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;PEG 3000, sodium chloride, hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.278
|
|
1NA5
INTEGRIN ALPHA M I DOMAIN
Deposited 2002-11-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
144–335(192 aa)
Fragment:Alpha M I domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;298 K;PEG 8000, sodium chloride, potassium citrate, pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.50 Å
R-free 0.228
|
|
2LKE
Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails
Deposited 2011-10-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1129–1152(24 aa)
Fragment:C-terminal domain, UNP residues 1129-1152
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.6;308 K;Pressure ambient
NMR sample composition
0.7 mM [1H] MYR-ALPHA-M-1, 200 mM [U-99% 2H] Dodecylphosphocholine-2, 10 mM sodium phosphate-3, 10 % [U-99% 2H] D2O-4, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM [1H] MYR-ALPHA-M-5, 200 mM [U-99% 2H] Dodecylphosphocholine-6, 10 mM sodium phosphate-7, 100 % [U-99% 2H] D2O-8, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2LKJ
Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails
Deposited 2011-10-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1129–1152(24 aa)
Fragment:C-terminal domain, UNP residues 1129-1152
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.6;308 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition
0.7 mM [1H] MYR-P-ALPHA-M-1, 200 mM [U-99% 2H] Dodecylphosphocholine-2, 10 mM sodium phosphate-3, 10 % [U-99% 2H] D2O-4, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM [1H] MYR-P-ALPHA-M-5, 200 mM [U-99% 2H] Dodecylphosphocholine-6, 10 mM sodium phosphate-7, 100 % [U-99% 2H] D2O-8, 100% D2O | 100% D2O
|
Resolution not provided
|
|
3QA3
Crystal Structure of A-domain in complex with antibody
Deposited 2011-01-10
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
148–337(190 aa)
Fragment:UNP residues 148-337
|
Mutation:I316G
|
EDO 1,2-ETHANEDIOL × 4
GOL GLYCEROL × 3
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;298 K;13% PEG8000, Tris pH 8.2, 0.25M NaCl, 10mM CaCl2, 1mM PMSF, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.224
|
|
3QA3
Crystal Structure of A-domain in complex with antibody
Deposited 2011-01-10
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
148–337(190 aa)
Fragment:UNP residues 148-337
|
Mutation:I316G
|
GOL GLYCEROL × 2
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;298 K;13% PEG8000, Tris pH 8.2, 0.25M NaCl, 10mM CaCl2, 1mM PMSF, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.224
|
|
3QA3
Crystal Structure of A-domain in complex with antibody
Deposited 2011-01-10
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
148–337(190 aa)
Fragment:UNP residues 148-337
|
Mutation:I316G
|
EDO 1,2-ETHANEDIOL × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;298 K;13% PEG8000, Tris pH 8.2, 0.25M NaCl, 10mM CaCl2, 1mM PMSF, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.224
|
|
3QA3
Crystal Structure of A-domain in complex with antibody
Deposited 2011-01-10
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
148–337(190 aa)
Fragment:UNP residues 148-337
|
Mutation:I316G
|
EDO 1,2-ETHANEDIOL × 3
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.2;298 K;13% PEG8000, Tris pH 8.2, 0.25M NaCl, 10mM CaCl2, 1mM PMSF, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 3.00 Å
R-free 0.224
|
|
4M76
Integrin I domain of complement receptor 3 in complex with C3d
Deposited 2013-08-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
143–337(195 aa)
Fragment:unp residues 143-337
|
Not recorded
|
NI NICKEL (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;PEG 3350, pH 7, vapor diffusion, hanging drop, temperature 298K
|
Resolution 2.80 Å
R-free 0.242
|
|
4XW2
Structural basis for simvastatin competitive antagonism of complement receptor 3
Deposited 2015-01-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
145–337(193 aa)
Fragment:UNP residues 145-337
|
Not recorded
|
MG MAGNESIUM ION × 1
SIM Simvastatin acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.2 M sodium malonate pH 7.0, 20% (w/v) PEG 3350
|
Resolution 2.00 Å
R-free 0.232
|
|
6RHW
Crystal structure of human CD11b I-domain (CD11b-I) in complex with Staphylococcus aureus octameric bi-component leukocidin LukGH
Deposited 2019-04-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain C
143–337(195 aa)
|
Not recorded
|
DMS DIMETHYL SULFOXIDE × 24
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;Crystallization drops were prepared by mixing 1.0 uL LukGH/huCD11b-I complex (5.2 mg/mL) in 25 mM HEPES (pH 7.5), 1 mM MgCl2 with 0.5 uL reservoir solution containing 30% (v/v) Jeffamine-600 and 10% (v/v) DMSO.
|
Resolution 2.75 Å
R-free 0.281
|
|
7AKK
Structure of a complement factor-receptor complex
Deposited 2020-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
143–337(195 aa)
Chain H
143–337(195 aa)
|
Mutation:C128S,I316G
Mutation:C128S,I316G
|
GOL GLYCEROL × 3
K POTASSIUM ION × 2
MG MAGNESIUM ION × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;100 mM Tris-HCl (pH 8.0), 8% (w/v) polyethylene glycol (PEG) 8000
|
Resolution 3.40 Å
R-free 0.229
|
|
7P2D
Structure of alphaMbeta2/Cd11bCD18 headpiece in complex with a nanobody
Deposited 2021-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
17–772(756 aa)
|
Not recorded
|
CA CALCIUM ION × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;292 K;1:1 ratio with reservoir containing 1.25 M sodium malonate, 76 mM HEPES pH 8.0, 24 mM HEPES pH 6.5, and 0.5% Jeffamine ED2001 pH 7.0
|
Resolution 3.20 Å
R-free 0.295
|
|
7USL
Integrin alphaM/beta2 ectodomain in complex with adenylate cyclase toxin RTX751 and M1F5 Fab
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
17–1104(1088 aa)
|
Not recorded
|
CA CALCIUM ION × 33
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 11
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
7USM
Integrin alphaM/beta2 ectodomain
Deposited 2022-04-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
17–1104(1088 aa)
|
Not recorded
|
CA CALCIUM ION × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8CE6
Crystal structure of human Cd11b I domain in P212121 space group
Deposited 2023-02-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
149–337(189 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
GOL GLYCEROL × 7
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.15M ammonium sulfate
25% PEG4000
15% glycerol
|
Resolution 1.58 Å
R-free 0.208
|
|
8CE9
Crystal structure of human Cd11b I domain in C121 space group
Deposited 2023-02-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
149–337(189 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
EDO 1,2-ETHANEDIOL × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;25% PEG Smear Medium
0.1M cacodylate pH 5.5
0.2M ammonium sulfate
|
Resolution 2.11 Å
R-free 0.239
|
|
8CE9
Crystal structure of human Cd11b I domain in C121 space group
Deposited 2023-02-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
149–337(189 aa)
|
Not recorded
|
SO4 SULFATE ION × 3
EDO 1,2-ETHANEDIOL × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;25% PEG Smear Medium
0.1M cacodylate pH 5.5
0.2M ammonium sulfate
|
Resolution 2.11 Å
R-free 0.239
|
|
8VOH
HADDOCK models of human alphaM I-domain bound to the the N-terminal domain of the cytokine pleiotrophin
Deposited 2024-01-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
147–340(194 aa)
Fragment:I-domain, residues 147-340
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 0.1;Pressure 1
NMR sample composition
0.2 mM [U-13C; U-15N] human alphaM I-domain, 1 mM The N-terminal domain of pleiotrophin, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-15N] human alphaM I-domain, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-13C; U-15N] The N-terminal domain of pleiotrophin, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8VOI
HADDOCK models of active human alphaM I-domain bound to the the C-terminal domain of the cytokine pleiotrophin
Deposited 2024-01-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–331(184 aa)
Fragment:I-domain, residues 148-331
|
Not recorded
|
MG MAGNESIUM ION × 1
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 0.1;Pressure 1
NMR sample composition
0.3 mM [U-100% 13C; U-100% 15N] active human alphaM I-domain, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-100% 13C; U-100% 15N] The C-terminal Domain of Pleiotrophin, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM The C-terminal Domain of Pleiotrophin, 0.2 mM [U-100% 13C; U-100% 15N; U-80% 2H] active human alphaM I-domain, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
9GMU
Structure ofhuman aM ligand binding domain in complex with the aCR3 nanobody
Deposited 2024-08-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
145–337(193 aa)
Fragment:UNP residues 145-337
|
Not recorded
|
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;292 K;100 mM HEPES, pH 7.0, 1.5 M Li2S04.
|
Resolution 3.80 Å
R-free 0.298
|
|
9GMU
Structure ofhuman aM ligand binding domain in complex with the aCR3 nanobody
Deposited 2024-08-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
145–337(193 aa)
Fragment:UNP residues 145-337
|
Not recorded
|
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;292 K;100 mM HEPES, pH 7.0, 1.5 M Li2S04.
|
Resolution 3.80 Å
R-free 0.298
|
|
9RM9
Cryo-EM structure of alphaM/beta2 headpiece complex without alphaM I-domain - the consensus map from alphaM/beta2:C3d-anti-CR3-Nb headpiece complex
Deposited 2025-06-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
17–770(754 aa)
|
Not recorded
|
CA CALCIUM ION × 5
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
MN MANGANESE (II) ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;0.02 % w/v CHAPS added to sample just before vitrification
|
Resolution 2.60 Å
|
|
9RMA
Cryo-EM structure of alphaM I-domain:C3d-anti-CR3-Nb complex focused refinement from the alphaM/beta2:C3d-anti-CR3-Nb headpiece complex
Deposited 2025-06-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
17–770(754 aa)
|
Not recorded
|
MN MANGANESE (II) ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;0.02 % w/v CHAPS added to sample just before vitrification
|
Resolution 3.94 Å
|
|
9T3Y
Cryo-EM structure of alphaM/beta2:C3d-anti-CR3-Nb headpiece complex (HPO2 3D class reconstruction)
Deposited 2025-10-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
17–770(754 aa)
|
Not recorded
|
CA CALCIUM ION × 5
MN MANGANESE (II) ION × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;0.02 % w/v CHAPS added to sample just before vitrification
|
Resolution 3.44 Å
|
|
9T5V
Cryo-EM structure of alphaM/beta2:C3d-anti-CR3-Nb headpiece complex (HPO1 3D class reconstruction)
Deposited 2025-11-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
17–773(757 aa)
|
Not recorded
|
CA CALCIUM ION × 5
MN MANGANESE (II) ION × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;0.02 % w/v CHAPS added to sample just before vitrification
|
Resolution 3.06 Å
|
|
9T5W
Cryo-EM structure of mutant R61H alphaM/beta2 headpiece complex
Deposited 2025-11-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
17–770(754 aa)
|
Not recorded
|
CA CALCIUM ION × 5
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
MN MANGANESE (II) ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;0.02 % w/v CHAPS added to sample just before vitrification
|
Resolution 2.74 Å
|
|
9T5Z
Cryo-EM structure of alphaM/beta2:MEM148-Fab headpiece complex (without alphaM I-domain)
Deposited 2025-11-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
17–771(755 aa)
|
Not recorded
|
CA CALCIUM ION × 5
MN MANGANESE (II) ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|